Siren LLC’s Whitehawk Therapeutics WHWK Stock Holding History

Siren LLC’s Portfolio WHWK Stock Details WHWK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.18M	Hold	2,082,000	–	–	0.2%	68
2025 Q4	$5.04M	Hold	2,082,000	–	–	0.15%	79
2025 Q3	$3.96M	Hold	2,082,000	–	–	0.15%	73
2025 Q2	$3.89M	Hold	2,082,000	–	–	0.2%	71
2025 Q1	$3.71M	Buy	+2,082,000	New	+$5.44M	0.21%	69

Other funds holding WHWK

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

KCA

KVP Capital Advisors San Francisco, California $134M AUM

Yu Fan $97M AUM 57.2% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

Siren LLC's WHWK Position: Q1 2026 in Review

Siren LLC held its Whitehawk Therapeutics (WHWK) position steady in Q1 2026 at 2,082,000 shares worth $7.18M. The position accounts for 0.2% of the portfolio, ranked #68.

Siren LLC first reported a position in WHWK in Q1 2025 and has held it in 5 quarters since. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

Siren LLC held 2,082,000 shares of Whitehawk Therapeutics worth $7.18M as of Q1 2026.
Siren LLC left its Whitehawk Therapeutics share count unchanged in Q1 2026.
Whitehawk Therapeutics made up 0.2% of Siren LLC's portfolio in Q1 2026, its #68 holding.
Siren LLC first reported a position in Whitehawk Therapeutics in Q1 2025 and has held it in 5 quarters since.
62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on Siren LLC's 13F filing for Q1 2026, filed 14 May 2026.